Debt to Equity
since 2005

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, calculation

	Debt to equity	=	Total debt¹	÷	Stockholders’ equity¹
Dec 31, 2023	0.10	=	2,702,900)	÷	25,973,100)
Dec 31, 2022	0.12	=	2,701,400)	÷	22,664,000)
Dec 31, 2021	0.14	=	2,699,700)	÷	18,768,800)
Dec 31, 2020	0.24	=	2,695,700)	÷	11,025,300)
Dec 31, 2019	0.06	=	713,900)	÷	11,089,700)
Dec 31, 2018	0.08	=	708,500)	÷	8,757,300)
Dec 31, 2017	0.11	=	703,453)	÷	6,144,078)
Dec 31, 2016	0.11	=	481,126)	÷	4,449,245)
Dec 31, 2015	0.10	=	375,510)	÷	3,654,837)
Dec 31, 2014	0.18	=	459,064)	÷	2,542,325)
Dec 31, 2013	0.26	=	505,638)	÷	1,952,076)
Dec 31, 2012	0.37	=	458,637)	÷	1,245,385)
Dec 31, 2011	0.90	=	438,039)	÷	485,732)
Dec 31, 2010	0.31	=	162,859)	÷	527,815)
Dec 31, 2009	0.27	=	109,022)	÷	396,762)
Dec 31, 2008	0.00	=	—)	÷	418,852)
Dec 31, 2007	0.43	=	200,000)	÷	460,267)
Dec 31, 2006	0.92	=	200,000)	÷	216,624)
Dec 31, 2005	1.75	=	200,000)	÷	114,002)

¹ US$ in thousands

Download chart

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, comparison to competitors

	Regeneron Pharmaceuticals Inc.	AbbVie Inc.	Amgen Inc.	Bristol-Myers Squibb Co.	Danaher Corp.	Eli Lilly & Co.	Gilead Sciences Inc.	Johnson & Johnson	Merck & Co. Inc.	Moderna Inc.	Pfizer Inc.	Thermo Fisher Scientific Inc.
Dec 31, 2023	0.10	5.73	10.37	1.35	0.34	2.34	1.09	0.43	0.93	0.04	0.81	0.75
Dec 31, 2022	0.12	3.67	10.64	1.27	0.39	1.52	1.19	0.52	0.67	0.06	0.37	0.78
Dec 31, 2021	0.14	4.98	4.97	1.24	0.49	1.88	1.27	0.46	0.87	0.05	0.50	0.85
Dec 31, 2020	0.24	6.58	3.51	1.34	0.53	2.94	1.73	0.56	1.26	0.05	0.63	0.63
Dec 31, 2019	0.06	—	3.09	0.91	0.72	5.88	1.09	0.47	1.02	0.03	0.83	0.60
Dec 31, 2018	0.08	—	2.71	0.52	0.35	1.30	1.28	0.51	0.94	0.03	0.66	0.69
Dec 31, 2017	0.11	7.33	1.40	0.68	0.40	1.18	1.64	0.57	0.71	—	0.60	0.83
Dec 31, 2016	0.11	7.95	1.16	0.41	0.53	0.74	1.39	0.39	0.62	—	0.71	0.77
Dec 31, 2015	0.10	8.03	1.12	0.47	0.54	0.55	1.20	0.28	0.59	—	0.60	0.59
Dec 31, 2014	0.18	8.62	1.19	0.53	0.15	0.52	0.80	0.27	0.44	—	0.51	0.71
Dec 31, 2013	0.26	3.28	1.45	0.55	0.16	0.30	0.58	0.25	0.50	—	0.48	0.62
Dec 31, 2012	0.37	4.66	1.39	0.54	0.28	0.37	0.88	0.25	0.39	—	0.46	0.46
Dec 31, 2011	0.90	—	1.13	0.34	0.31	0.52	1.13	0.34	0.32	—	0.47	0.47
Dec 31, 2010	0.31	—	0.56	0.35	0.21	0.56	0.59	0.30	0.33	—	0.50	0.14
Dec 31, 2009	0.27	—	0.47	0.43	0.25	0.70	0.18	0.29	0.30	—	0.54	0.14
Dec 31, 2008	0.00	—	0.50	0.55	0.27	1.55	0.31	0.28	0.33	—	0.30	0.14
Dec 31, 2007	0.43	—	0.63	0.59	0.41	0.37	0.38	0.22	0.32	—	0.20	0.15
Dec 31, 2006	0.92	—	0.48	0.74	0.37	0.34	0.77	0.17	0.39	—	0.11	0.19
Dec 31, 2005	1.75	—	0.19	0.77	0.21	0.60	0.10	0.07	0.45	—	0.27	0.21

Download chart

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

	Regeneron Pharmaceuticals Inc.	Pharmaceuticals, Biotechnology & Life Sciences
Dec 31, 2023	0.10	0.98
Dec 31, 2022	0.12	0.79
Dec 31, 2021	0.14	0.92
Dec 31, 2020	0.24	1.14
Dec 31, 2019	0.06	1.10
Dec 31, 2018	0.08	0.94
Dec 31, 2017	0.11	0.88
Dec 31, 2016	0.11	0.79
Dec 31, 2015	0.10	0.68
Dec 31, 2014	0.18	0.55
Dec 31, 2013	0.26	0.52
Dec 31, 2012	0.37	0.51
Dec 31, 2011	0.90	0.46
Dec 31, 2010	0.31	0.39
Dec 31, 2009	0.27	0.39
Dec 31, 2008	0.00	0.37
Dec 31, 2007	0.43	0.30
Dec 31, 2006	0.92	0.25
Dec 31, 2005	1.75	0.29

Download chart

Regeneron Pharmaceuticals Inc., debt to equity, long-term trends, comparison to industry (health care)

	Regeneron Pharmaceuticals Inc.	Health Care
Dec 31, 2023	0.10	0.81
Dec 31, 2022	0.12	0.72
Dec 31, 2021	0.14	0.78
Dec 31, 2020	0.24	0.90
Dec 31, 2019	0.06	0.91
Dec 31, 2018	0.08	0.87
Dec 31, 2017	0.11	0.79
Dec 31, 2016	0.11	0.75
Dec 31, 2015	0.10	0.68
Dec 31, 2014	0.18	0.52
Dec 31, 2013	0.26	0.49
Dec 31, 2012	0.37	0.51
Dec 31, 2011	0.90	0.45
Dec 31, 2010	0.31	0.41
Dec 31, 2009	0.27	0.41
Dec 31, 2008	0.00	0.41
Dec 31, 2007	0.43	0.36
Dec 31, 2006	0.92	0.33
Dec 31, 2005	1.75	0.30

Download chart

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)